Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York 10029-6574, USA.
Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029-6574, USA.
Nat Microbiol. 2017 Mar 27;2:17037. doi: 10.1038/nmicrobiol.2017.37.
During the last few decades, the global incidence of dengue virus (DENV) has increased dramatically, and it is now endemic in more than 100 countries. To establish a productive infection in humans, DENV uses different strategies to inhibit or avoid the host innate immune system. Several DENV proteins have been shown to strategically target crucial components of the type I interferon system. Here, we report that the DENV NS2B protease cofactor targets the DNA sensor cyclic GMP-AMP synthase (cGAS) for lysosomal degradation to avoid the detection of mitochondrial DNA during infection. Such degradation subsequently results in the inhibition of type I interferon production in the infected cell. Our data demonstrate a mechanism by which cGAS senses cellular damage upon DENV infection.
在过去的几十年中,登革热病毒 (DENV) 的全球发病率急剧上升,现已在 100 多个国家流行。为了在人类中建立有效的感染,DENV 采用了不同的策略来抑制或避免宿主固有免疫系统。已经证明,几种 DENV 蛋白可以有策略地靶向 I 型干扰素系统的关键组成部分。在这里,我们报告 DENV NS2B 蛋白酶辅因子将 DNA 传感器环鸟苷酸-腺苷酸合酶 (cGAS) 靶向溶酶体降解,以避免在感染过程中检测到线粒体 DNA。这种降解随后导致感染细胞中 I 型干扰素的产生受到抑制。我们的数据证明了 cGAS 在 DENV 感染时感知细胞损伤的机制。